GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 16.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 153,403 shares of the company's stock after buying an additional 21,629 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in GE HealthCare Technologies were worth $12,274,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. CoreFirst Bank & Trust purchased a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at $25,000. Runnymede Capital Advisors Inc. purchased a new position in GE HealthCare Technologies in the 4th quarter valued at about $28,000. LGT Financial Advisors LLC boosted its stake in shares of GE HealthCare Technologies by 46.2% during the 4th quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock worth $30,000 after purchasing an additional 123 shares during the last quarter. Accredited Wealth Management LLC purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter worth about $30,000. Finally, Ameriflex Group Inc. acquired a new position in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $31,000. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Trading Up 0.0%

GEHC traded up $0.03 on Thursday, reaching $76.15. 1,800,530 shares of the company's stock were exchanged, compared to its average volume of 3,507,785. The company's 50 day moving average is $71.38 and its 200-day moving average is $77.51. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.76 and a current ratio of 0.98. The company has a market cap of $34.87 billion, a price-to-earnings ratio of 16.03, a PEG ratio of 2.56 and a beta of 1.14.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, April 30th. The company reported $1.01 EPS for the quarter, topping the consensus estimate of $0.91 by $0.10. GE HealthCare Technologies had a return on equity of 24.95% and a net margin of 11.02%. The firm had revenue of $4.78 billion for the quarter, compared to analyst estimates of $4.66 billion. During the same period in the previous year, the company posted $0.90 EPS. GE HealthCare Technologies's revenue for the quarter was up 2.7% on a year-over-year basis. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 25th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.18%. The ex-dividend date is Friday, July 25th. GE HealthCare Technologies's payout ratio is 2.95%.

GE HealthCare Technologies declared that its Board of Directors has approved a share repurchase program on Wednesday, April 30th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the company to buy up to 3.1% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's board of directors believes its stock is undervalued.

Analysts Set New Price Targets

GEHC has been the topic of a number of analyst reports. The Goldman Sachs Group decreased their target price on shares of GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. BTIG Research set a $95.00 price objective on GE HealthCare Technologies and gave the stock a "buy" rating in a report on Monday, April 14th. Wall Street Zen upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research note on Saturday, May 31st. Wells Fargo & Company reduced their target price on GE HealthCare Technologies from $103.00 to $89.00 and set an "overweight" rating on the stock in a research report on Thursday, May 1st. Finally, Citigroup lowered their price target on GE HealthCare Technologies from $105.00 to $86.00 and set a "buy" rating for the company in a report on Wednesday, April 30th. Three analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $88.27.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.